Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Pancreatic Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

Phase

Status

Completed 5 Terminated 4 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Tongue Neoplasms 4 Head and Neck Neoplasms 4 Prostatic Neoplasms 2 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Squamous Cell 1 Mucositis 1 Mouth Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Carcinoma 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 16 Taxes 8 pembrolizumab 5 Specimen Handling 4 Radiosurgery 4 Capecitabine 4 Ascorbic Acid 4 Albumin-Bound Paclitaxel 4 Surgical Procedures, Operative 3 Secretin 3 Oxaliplatin 3 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Fluorouracil 3 Cisplatin 3 Biopsy 3 130-nm albumin-bound paclitaxel 3 palbociclib 2 methylnaltrexone 2 folfirinox 2 fludarabine 2 entinostat 2 durvalumab 2 aldesleukin 2 Trastuzumab 2 Radiotherapy 2 Radiation 2 Palliative Care 2 Paclitaxel 2 Metformin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03541486 2025-03-10

XACT-PANC-2

University of Iowa

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡